|
RABIF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.082600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.951180E-01 |
| Normal-vs-Stage2 |
5.866800E-01 |
| Normal-vs-Stage3 |
5.687200E-01 |
| Normal-vs-Stage4 |
7.822400E-01 |
| Stage1-vs-Stage2 |
7.762800E-01 |
| Stage1-vs-Stage3 |
6.361200E-01 |
| Stage1-vs-Stage4 |
4.503400E-01 |
| Stage2-vs-Stage3 |
9.321400E-01 |
| Stage2-vs-Stage4 |
7.765600E-01 |
| Stage3-vs-Stage4 |
8.158600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.939820E-01 |
| Normal-vs-AfricanAmerican |
4.601000E-01 |
| Normal-vs-Asian |
9.507000E-01 |
| Caucasian-vs-AfricanAmerican |
9.591600E-02 |
| Caucasian-vs-Asian |
7.012600E-01 |
| AfricanAmerican-vs-Asian |
7.927400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.917800E-01 |
| Normal-vs-Female |
1.652080E-02 |
| Male-vs-Female |
3.920900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.051200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.928600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.152800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.688210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.603000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.521400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.827600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.881600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.271000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.913570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.824600E-01 |
| Normal-vs-Grade 2 |
1.956000E-01 |
| Normal-vs-Grade 3 |
7.047600E-01 |
| Normal-vs-Grade 4 |
3.654000E-01 |
| Grade 1-vs-Grade 2 |
5.036400E-01 |
| Grade 1-vs-Grade 3 |
3.370000E-01 |
| Grade 1-vs-Grade 4 |
6.176000E-01 |
| Grade 2-vs-Grade 3 |
3.232400E-01 |
| Grade 2-vs-Grade 4 |
9.570800E-01 |
| Grade 3-vs-Grade 4 |
4.746800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.767750E-02 |
| Normal-vs-ccB subtype |
6.656200E-01 |
| ccA subtype-vs-ccB subtype |
5.934100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.339800E-01 |
| Normal-vs-N1 |
5.285000E-01 |
| N0-vs-N1 |
8.012600E-01 |
|
|
